Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,127 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00062335 | High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | terminated | Phase 1 | 14 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 24, 2012 | clinicaltrials |
| NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 86 | European Organisation for Research and Treatment of Cancer - EORTC |
| 5 |
| Sep 24, 2012 |
| clinicaltrials |
| NCT00064207 | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00066391 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | terminated | Phase 2 / Phase 3 | 88 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00079261 | Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00085228 | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 24, 2012 | clinicaltrials |
| NCT00085475 | Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma | completed | Phase 2 | 17 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 24, 2012 | clinicaltrials |
| NCT00110045 | Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant | completed | Phase 2 | 171 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00128700 | Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 1 / Phase 2 | 20 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00614978 | Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer(LAPTEM) | completed | Phase 1 | 18 | Jules Bordet InstituteOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00068757 | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | completed | Phase 1 | 23 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 12, 2012 | clinicaltrials |
| NCT00830778 | Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy | completed | Phase 3 | 336 | Baki TopalOTHER | 1 | Sep 12, 2012 | clinicaltrials |
| NCT01009593 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 3 | 1,035 | AbbottINDUSTRY | 29 | Sep 10, 2012 | clinicaltrials |
| NCT00033904 | Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer | completed | Phase 3 | 650 | Agenus Inc.INDUSTRY | 11 | Sep 7, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00041301 | Assessing Quality of Life of Patients With Prostate Cancer | completed | — | 625 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Aug 27, 2012 | clinicaltrials |
| NCT00045019 | Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care | completed | — | 795 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Aug 27, 2012 | clinicaltrials |
| NCT00052299 | Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia(AML-17) | completed | Phase 3 | 472 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 27, 2012 | clinicaltrials |
| NCT00828620 | Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project | terminated | — | 21 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 10 | Aug 7, 2012 | clinicaltrials |
| NCT00069745 | Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen | completed | Phase 3 | — | AgennixINDUSTRY | 15 | Aug 7, 2012 | clinicaltrials |
| NCT00343616 | Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 | completed | Phase 3 | 135 | ETOP IBCSG Partners FoundationNETWORK | 6 | Jul 27, 2012 | clinicaltrials |
| NCT00006121 | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | terminated | Phase 2 | 18 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 24, 2012 | clinicaltrials |
| NCT00014625 | E7070 in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 28 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 24, 2012 | clinicaltrials |
| NCT00022594 | Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer | completed | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Jul 24, 2012 | clinicaltrials |
| NCT00027677 | Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors | completed | Phase 1 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 24, 2012 | clinicaltrials |
| NCT00027781 | MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 37 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 24, 2012 | clinicaltrials |
| NCT00039364 | Imatinib Mesylate in Treating Patients With Gliomas | completed | Phase 2 | 112 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 24, 2012 | clinicaltrials |
| NCT00091234 | Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia(AML-19) | unknown | Phase 2 / Phase 3 | 279 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 24, 2012 | clinicaltrials |
| NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia(AML-14A) | unknown | Phase 1 / Phase 2 | 114 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 20, 2012 | clinicaltrials |
| NCT00393939 | Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer(SUN 1064) | completed | Phase 3 | 594 | PfizerINDUSTRY | 27 | Jul 19, 2012 | clinicaltrials |
| NCT00003803 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed | terminated | Phase 3 | 158 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00004920 | Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura | completed | Phase 3 | 256 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jul 18, 2012 | clinicaltrials |
| NCT00021112 | Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer | terminated | Phase 2 | 5 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 18, 2012 | clinicaltrials |
| NCT00028704 | Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy | terminated | Phase 3 | 26 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 18, 2012 | clinicaltrials |
| NCT00028873 | R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | completed | Phase 2 | 35 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 18, 2012 | clinicaltrials |
| NCT00041236 | Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 39 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 18, 2012 | clinicaltrials |
| NCT00041249 | Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | 64 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00049660 | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 / Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00066339 | Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00227630 | Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 59 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 18, 2012 | clinicaltrials |
| NCT00389688 | Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery | terminated | Phase 2 | 13 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00006122 | Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | completed | Phase 2 | 106 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 16, 2012 | clinicaltrials |
| NCT00014326 | Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma | terminated | Phase 3 | 204 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 16, 2012 | clinicaltrials |
| NCT00030511 | Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer | terminated | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 16, 2012 | clinicaltrials |
| NCT00074074 | Infliximab in Treating Patients With Myelodysplastic Syndrome | completed | Phase 2 | 46 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 16, 2012 | clinicaltrials |
| NCT00077116 | Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome | completed | Phase 2 | 31 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 16, 2012 | clinicaltrials |
| NCT00091156 | Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | terminated | Phase 3 | 598 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 16, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials